Interview Portrays the Benefits of Cannabis-Related Products to Millions of Chinese Viewers Around the World
SAN DIEGO, Jan. 11, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) is pleased to announce that the Company’s CEO was featured in a series of interviews on Phoenix TV, one of China’s largest TV networks, outlining the history and the various benefits of the Company’s products.
The interviews, which were broadcast on Dec. 23 and Dec. 30 of 2016, summarized the personal experiences of CEO Dr. Stuart Titus and also detailed the disruptive nature and enormous economic potential for Medical Marijuana, Inc.’s cannabidiol (CBD) products. The broadcast also showcased the Company’s major sales subsidiary HempMeds® and flagship product Real Scientific Hemp Oil™ (RSHO™).
The Phoenix TV segments discussed developments such as athletes preferring cannabis to pharmaceutical treatments currently on the market – and also laid out the vast economic opportunities that CBD products have brought to the ever-expanding cannabis industry.
“If you extrapolate Colorado to California where we have a much larger population, we believe that this now-legal market is going to represent about $35 billion, so this will be the largest cannabis market in the world,” Phoenix TV quoted Titus as saying. “Not only will this add to our national GDP, it’s going to improve employment with tremendous job creation.”
The interviews were viewable via the Chinese Finance Network, a program featured on Phoenix TV. The segments can be viewed HERE and HERE. Phoenix TV currently airs to an estimated audience of 300 Million people around the globe.
Medical Marijuana, Inc. was the first publicly traded cannabis company in the United States initially hitting the market in 2009. For more information for potential investors, please visit the Investor Relations or Overview page of Medical Marijuana, Inc.’s website or check out the recent OTC Market Report HERE.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
P. 888-829- 0070
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: [email protected]